HALE COSMECEUTICALS COMPLEXION PERFECTION SUNSCREEN SPF 20- titanium dioxide cream 
Hale Cosmeceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Hale Cosmeceuticals Complexion Perfection Sunscreen SPF 20+

Drug Facts

Active Ingredients

Titanium Dioxide 5.0%

Purpose

Sunscreen

Uses

Warnings

Do not use

  • on damaged or broken skin

Stop use and ask a doctor if

  • rash occurs

When using this product

  • keep out of eyes. Rinse with water to remove.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center

Directions

Skin Cancer/Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.

Other Information

Inactive Ingredients

Questions or comments?

Visit www.halecosmeceuticals.com or call toll-free (800) 951-7005.

Package Labeling:

Bottle

HALE COSMECEUTICALS COMPLEXION PERFECTION SUNSCREEN SPF 20 
titanium dioxide cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71987-007
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE50 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
POLYHYDROXYSTEARIC ACID (2300 MW) (UNII: YXH47AOU0F)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
SQUALANE (UNII: GW89575KF9)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
PEG-100 STEARATE (UNII: YD01N1999R)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
POLYOXYL 20 CETOSTEARYL ETHER (UNII: YRC528SWUY)  
BORAGO OFFICINALIS SEED (UNII: 2GXJ790US0)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
NIACINAMIDE (UNII: 25X51I8RD4)  
GLYCERIN (UNII: PDC6A3C0OX)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
KOJIC DIPALMITATE (UNII: 13N249RWTM)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
SORBIC ACID (UNII: X045WJ989B)  
OLIVE OIL (UNII: 6UYK2W1W1E)  
TOCOPHEROL (UNII: R0ZB2556P8)  
PALMITOYL LYSYLDIOXYMETHIONYLLYSINE (UNII: T7A529FB8O)  
UREA (UNII: 8W8T17847W)  
XANTHAN GUM (UNII: TTV12P4NEE)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71987-007-0130 mL in 1 TUBE; Type 0: Not a Combination Product12/01/202012/31/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35212/01/202012/31/2024
Labeler - Hale Cosmeceuticals, Inc. (168405822)

Revised: 12/2022
Document Id: efcf7ca9-a38f-323a-e053-2995a90a83fc
Set id: b5a7ab9b-a78a-8ffc-e053-2995a90a2b8b
Version: 4
Effective Time: 20221214
 
Hale Cosmeceuticals, Inc.